高级检索
当前位置: 首页 > 详情页

Global, regional and national epidemiology of acute myeloid leukemia (1990-2021): a statistical analysis of incidence, mortality, and DALYs

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]CAMS & PUMC, Inst Blood Transfus, Chengdu, Peoples R China [2]Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Urol, Chengdu, Peoples R China [3]Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Canc Inst, Chengdu, Peoples R China [4]South China Univ Technol, Guangzhou Peoples Hosp 1, Dept Hematol, Guangzhou, Peoples R China [5]Sun Yat Sen Univ, Affiliated Hosp 7, Clin Med Res Ctr, Shenzhen, Peoples R China [6]Chengdu Med Coll, Chengdu, Peoples R China [7]BeiGene Beijing Co Ltd, Sci Affairs, Beijing, Peoples R China [8]Chengdu Univ Tradit Chinese Med, Sch Basic Med Sci, Chengdu, Peoples R China [9]Jinfeng Lab, Chongqing, Peoples R China
出处:
ISSN:

关键词: Acute myeloid leukemia global burden of disease study incidence mortality disability-adjusted life years

摘要:
BackgroundThis study provides a comprehensive analysis of the global, regional, and national epidemiology of acute myeloid leukemia (AML) from 1990 to 2021, focusing on incidence, mortality, and disability-adjusted life years (DALYs).MethodsUsing data from the Global Burden of Disease (GBD) study, we investigated the trends and patterns of AML across 204 countries and territories during 1990 to 2021. All statistical analyses and data visualizations were performed using R (version 4.4.2) and JD_GBDR (V2.36).ResultsThe global incidence of AML increased by 82.25% from 79.37 x 10(3) cases in 1990 to 144.65 x 10(3) cases in 2021, with significant variations across regions. AML-related deaths increased by 73.77% globally, from 74.92 x 10(3) in 1990 to 130.19 x 10(3) in 2021. DALYs rose by 23.70%, from 3342.91 x 10(3) in 1990 to 4135.06 x 10(3) in 2021.ConclusionsHigh SDI regions face higher incidence and mortality due to advanced diagnostics and aging, while low-middle SDI regions show rapid increases likely due to urbanization and lifestyle changes. Addressing these disparities requires improved healthcare infrastructure, early detection, and targeted interventions, particularly in low- and middle-income countries (LMICs).

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 2 区 医学
小类 | 2 区 医学:内科
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 医学:内科
JCR分区:
出版当年[2024]版:
Q1 MEDICINE, GENERAL & INTERNAL
最新[2024]版:
Q1 MEDICINE, GENERAL & INTERNAL

影响因子: 最新[2024版] 最新五年平均 出版当年[2024版] 出版当年五年平均 出版前一年[2024版]

第一作者:
第一作者机构: [1]CAMS & PUMC, Inst Blood Transfus, Chengdu, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [2]Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Urol, Chengdu, Peoples R China [3]Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Canc Inst, Chengdu, Peoples R China [9]Jinfeng Lab, Chongqing, Peoples R China [*1]department of Urology, sichuan Provincial People’s Hospital, Universityof electronic science and Technology of china, chengdu, china [*2]cancer institute, sichuanProvincial People’s Hospital, University of electronic science and Technology of china, chengdu, china
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:65768 今日访问量:2 总访问量:5150 更新日期:2025-12-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号